173 related articles for article (PubMed ID: 16886612)
1. C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil.
Burbano RR; Assumpção PP; Leal MF; Calcagno DQ; Guimarães AC; Khayat AS; Takeno SS; Chen ES; De Arruda Cardoso Smith M
Anticancer Res; 2006; 26(4B):2909-14. PubMed ID: 16886612
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma.
Calcagno DQ; Leal MF; Taken SS; Assumpção PP; Demachki S; Smith Mde A; Burbano RR
Anticancer Res; 2005; 25(6B):4069-74. PubMed ID: 16309200
[TBL] [Abstract][Full Text] [Related]
3. Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma.
Costa Raiol LC; Figueira Silva EC; Mendes da Fonseca D; Leal MF; Guimarães AC; Calcagno DQ; Khayat AS; Assumpção PP; de Arruda Cardoso Smith M; Burbano RR
Cancer Genet Cytogenet; 2008 Feb; 181(1):31-5. PubMed ID: 18262050
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas.
Wu CW; Chen GD; Fann CS; Lee AF; Chi CW; Liu JM; Weier U; Chen JY
Genes Chromosomes Cancer; 2002 Nov; 35(3):219-31. PubMed ID: 12353264
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization.
Takeno SS; Leal MF; Lisboa LC; Lipay MV; Khayat AS; Assumpção PP; Burbano RR; Smith Mde A
Cancer Genet Cytogenet; 2009 Apr; 190(1):1-7. PubMed ID: 19264226
[TBL] [Abstract][Full Text] [Related]
6. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas.
El-Rifai W; Harper JC; Cummings OW; Hyytinen ER; Frierson HF; Knuutila S; Powell SM
Cancer Res; 1998 Jan; 58(1):34-7. PubMed ID: 9426053
[TBL] [Abstract][Full Text] [Related]
7. DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey.
Gümüs-Akay G; Unal AE; Elhan AH; Bayar S; Karadayt K; Sunguroglu A; Kadikiran A; Tükün A
Arch Med Res; 2009 Oct; 40(7):551-60. PubMed ID: 20082868
[TBL] [Abstract][Full Text] [Related]
8. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer.
Hidaka S; Yasutake T; Kondo M; Takeshita H; Yano H; Haseba M; Tsuji T; Sawai T; Nakagoe T; Tagawa Y
Anticancer Res; 2003; 23(4):3353-7. PubMed ID: 12926075
[TBL] [Abstract][Full Text] [Related]
9. MYC insertions in diffuse-type gastric adenocarcinoma.
Calcagno DQ; Guimarães AC; Leal MF; Seabra AD; Khayat AS; Pontes TB; Assumpção PP; De Arruda Cardoso Smith M; Burbano RR
Anticancer Res; 2009 Jul; 29(7):2479-83. PubMed ID: 19596917
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
11. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations in primary gastric cancers analyzed by comparative genomic hybridization and clinicopathological factors.
Nakanishi M; Sakakura C; Fujita Y; Yasuoka R; Aragane H; Koide K; Hagiwara A; Yamaguchi T; Nakamura Y; Abe T; Inazawa J; Yamagishi H
Hepatogastroenterology; 2000; 47(33):658-62. PubMed ID: 10919006
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss.
Moskaluk CA; Hu J; Perlman EJ
Genes Chromosomes Cancer; 1998 Aug; 22(4):305-11. PubMed ID: 9669668
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chromosomal aberrations between primary tumors and their synchronous lymph-node metastases in intestinal-type gastric carcinoma.
Liu XP; Li DY; Liu XL; Xu JD; Furuya T; Kawauchi S; Oga A; Sasaki K
Pathol Res Pract; 2009; 205(2):105-11. PubMed ID: 19041191
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
16. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
17. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization in primary sinonasal adenocarcinomas.
Ariza M; Llorente JL; Alvarez-Marcas C; Baragaño L; Salas A; Rodriguez Prado N; Hermsen M; Suárez C; Sampedro A
Cancer; 2004 Jan; 100(2):335-41. PubMed ID: 14716769
[TBL] [Abstract][Full Text] [Related]
19. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
